In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Healthy

In brief

The investigators propose to study oral commercial silver nanoparticle products on human enzyme activity.

Key facts

Study ID

NCT01405794

Run by

University of Utah

People needed

12

Starts

2011-07-01

Expected to finish

2011-11-01

Last updated by the study team

2016-07-04

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18-80 years old without debilitating chronic disease or history of cardiovascular event.

You may not qualify if…

• Women physically capable of becoming pregnant, who are not using 2 barrier methods of birth control;
• Any female who is nursing;
• History of heavy metal allergy;
• History of asthma or Chronic Obstructive Pulmonary Disease;
• History of renal impairment;
• Symptoms of active upper respiratory disease at time of consent;
• Smoking more than 5 cigarettes or equivalent and not able to stop for 48 hours;
• Ability to discontinue chronic medications or nutraceuticals for 20 days or 5 half-lives of the agent, whichever is longer.

Where it is running

• University of Utah — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.